Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
Cancer Research and Treatment. 2016;48(4):1338-1350 
Prognostic Impact of Triple Negative Phenotype in Conservatively Treated Breast Cancer
The Breast Journal. 2011;17(4):377-382
A novel potential prognostic marker SIRT1 on tumor invasion and metastasis, and tumor recurrence in triple negative breast cancer
Annals of Oncology. 2015;26:iii15
Expression and Prognostic Significance of BANF1 in Triple-Negative Breast Cancer
Cancer Management and Research. 2020;Volume 12:145-150
Notch-4 is a novel therapeutic target and prognostic marker for triple negative breast cancer
The Breast. 2017;32:S96
Is triple negative a prognostic factor in breast cancer?
Breast Cancer. 2008;15(4):303-308
Triple-Negative Breast Cancer: Expression of Hypoxia-Inducible Factor 1α in Triple-Negative Breast Cancer with Metastasis to Lymph Nodes
Breast Cancer and Surgery. 2018;
Association between aspirin use triple negative breast cancer: More benefit is expected
Cancer Epidemiology. 2017;48:157
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
Breast Cancer: Targets and Therapy. 2018;Volume 10:177-194
Clinico-Pathological Characteristics of Triple Negative and Non Triple Negative High Grade Breast Carcinomas with and without Basal Marker (CK5/6 and EGFR) Expression at a Rural Tertiary Hospital in India
Breast Cancer: Basic and Clinical Research. 2012;6:BCBCR.S8611